Cardiovascular drugs and therapy
Comment on "Superior Cerebrovascular Outcomes with Tirzepatide Versus Semaglutide in Diabetic CABG Patients: A Global Network Study of Propensity-Matched Patients".
Siyi Liu
Published: 202510.1007/s10557-025-07812-z
No abstract available for this study.